A first-of-its-kind machine learning-based coronavirus screening device has gained emergency use authorization (EUA) from the US Food and Drug Administration. The product could be key to quickly and cheaply identifying people with COVID-19 as schools and workplaces reopening during the pandemic.
The FDA on 22 March announced that it gave marketing authorization to Tiger Tech’s COVID Plus Monitor. The device...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?